Pharmanex BioGinkgo. Mental Sharpness. 60 Tablets
Recalling firm: Nu Skin Enterprises Inc.
Nu Skin announces a voluntary field action for Pharmanex BioGinkgo due to undeclared allergen; wheat.
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Aug 22, 2017.
Check your package
Compare the exact product and package details with the label you have.
FDA code information
Batches: DL14951-07, DL31551-07, DL21161-07
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Pharmanex BioGinkgo. Mental Sharpness. 60 Tablets
Original FDA recall reason
Nu Skin announces a voluntary field action for Pharmanex BioGinkgo due to undeclared allergen; wheat.
Recall details
- Recall number
- F-1578-2017
- Event ID
- 76535
- FDA status
- Terminated
- Initiated
- Feb 13, 2017
- Reported
- Mar 15, 2017
- Classified
- Mar 8, 2017
- Terminated
- Aug 22, 2017
- Quantity
- 40,158
- Location
- Provo, UT, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
Where it was distributed
Nationwide, Canadian and other foreign consignees. No VA/govt/military consignees.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.